Anti-Müllerian hormone, or AMH, has become one of the most commonly ordered fertility tests for women in their late 30s and early 40s. It’s often discussed as a marker of “ovarian reserve,” and for many women, receiving an AMH result — especially a lower-than-expected one — can feel like a verdict on their fertility. Understanding what this test actually measures, and just as importantly what it doesn’t measure, can help put the results into a more accurate and less anxiety-provoking context.
Part of what makes AMH results so emotionally charged is how the test is often marketed and discussed outside of a clinical setting, sometimes framed in ways that suggest a single number can summarize a woman’s entire reproductive future. In reality, ovarian reserve is only one piece of a much larger and more nuanced fertility picture, and AMH itself has meaningful limitations as a predictive tool. Approaching an AMH result with informed skepticism about what it can and cannot tell you is often more useful than either dismissing it entirely or treating it as the final word.
What AMH Actually Measures
AMH is produced by small follicles in the ovaries, and its levels are generally thought to correlate with the size of the remaining egg supply, according to information from the American College of Obstetricians and Gynecologists. It’s a useful marker for estimating how a woman might respond to ovarian stimulation in a fertility treatment context, such as IVF. However, it is a measure of egg quantity, not egg quality, and quality is influenced by different biological factors, many of which are more closely tied to age itself than to AMH.
What Research Shows About AMH After 35
Research indicates that AMH levels do tend to decline with age, and this decline can become more noticeable after the mid-to-late 30s, consistent with the general pattern of declining ovarian reserve discussed in the context of perimenopause and ovarian reserve after 35. That said, AMH values vary considerably between individuals of the same age, and a lower value doesn’t mean pregnancy is impossible — many women with lower AMH conceive naturally, sometimes without ever knowing their level was on the lower end of the range.
What AMH Cannot Tell You
One of the most important, and most often overlooked, points about AMH is that it is not an effective predictor of natural conception timing or overall chance of pregnancy in women without a fertility diagnosis. Several studies have found that AMH has limited value in predicting whether a woman trying to conceive naturally will become pregnant within a given timeframe. It also doesn’t measure egg quality, chromosomal health of eggs, or the likelihood of a healthy pregnancy once conception occurs. Interpreting a single AMH number as a definitive fertility “score” tends to overstate what the test can actually tell you.
How AMH Is Used in Fertility Treatment
Where AMH tends to be most clinically useful is in planning for fertility treatments like IVF, where it helps providers estimate how many eggs might be retrieved during a stimulation cycle and adjust medication protocols accordingly. In this context, it’s one data point among several — including antral follicle count and clinical history — that inform a treatment plan. This is part of why some clinics also discuss which IVF add-ons have evidence behind them when reviewing a personalized protocol.
Processing an Unexpected Result
Receiving a lower-than-expected AMH result can bring up real emotional responses, including anxiety or grief about assumptions made regarding one’s fertility timeline. These feelings are common and understandable. Speaking with a reproductive endocrinologist who can walk through what the number does and doesn’t mean for individual circumstances is often more helpful than researching population-level statistics alone, and connecting with a therapist familiar with fertility concerns can also provide valuable support.
How AMH Compares to Other Fertility Markers
AMH is often ordered alongside other tests, including follicle-stimulating hormone (FSH) and antral follicle count via ultrasound, and providers generally look at these markers together rather than relying on any single one. FSH, measured early in the cycle, reflects how hard the pituitary gland is working to stimulate the ovaries, and elevated levels can suggest reduced ovarian reserve, though like AMH it doesn’t predict egg quality. Antral follicle count, obtained through a transvaginal ultrasound, offers a direct visual estimate of the follicles available in a given cycle and is sometimes considered a complementary data point to AMH. None of these markers, alone or combined, can tell a woman with certainty whether she will conceive naturally or how long it might take, which is an important distinction to keep in mind when reviewing results.
Age Versus AMH as a Predictor
Interestingly, some research has found that chronological age remains a stronger predictor of natural conception likelihood and live birth rates than AMH level alone, particularly for women without a diagnosed fertility condition. This doesn’t mean AMH is unhelpful, but it does suggest that a woman with an average AMH for her age faces a fertility picture shaped primarily by age itself, while a woman with a lower-than-average AMH for her age isn’t necessarily facing a meaningfully different natural conception timeline than her same-age peers, according to some of the research in this space. This nuance is often lost in conversations that treat AMH as the single most important number to know.
Frequently Asked Questions
Is a low AMH the same as infertility?
No. Low AMH reflects a lower egg quantity estimate, not a diagnosis of infertility. Many women with lower AMH levels conceive naturally or with treatment.
Can AMH levels improve over time?
AMH generally reflects an underlying trend that declines gradually with age rather than something that can be meaningfully raised through lifestyle changes, though research in this area continues to evolve.
Should every woman over 35 get an AMH test?
This depends on individual circumstances and goals. Some providers recommend it as part of a fertility workup, while others reserve it for women planning treatment or with specific concerns. A discussion with a healthcare provider can help determine if it’s relevant for you.
Does AMH predict menopause timing?
Some research has explored AMH as a rough indicator of the general timeframe leading toward menopause, but it is not considered a precise predictor for any individual.
Can lifestyle changes raise my AMH level?
Current evidence does not show that diet, exercise, or supplements meaningfully raise AMH levels, since the hormone reflects a physiological trend tied primarily to age. Some studies have examined factors such as smoking, which may be associated with somewhat lower levels, though this remains an area of ongoing research.
Key Takeaways
- AMH estimates egg quantity, not egg quality, and doesn’t reliably predict natural conception timing.
- Levels naturally decline with age, though individual variation is significant.
- AMH is most clinically useful for planning fertility treatment protocols like IVF.
- A reproductive endocrinologist can help interpret results within a fuller clinical picture.
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.